Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons R.A. (Rudolf) de Boer
University Medical Center Groningen

R.A. (Rudolf) de Boer

Cardioloog & Hoofd Experimentele Cardiologie

Publicaties

Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction

Cardiovascular-Kidney-Metabolic Medication Eligibility Across National Survey, Community-Based, and Ambulatory Healthcare Samples

Framingham risk score associates with incident cancer and heart failure

Growth Differentiation Factor-15 and the Effect of Dapagliflozin in Heart Failure: Insights From the DAPA-HF Trial

Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study

Relative fat mass as a predictor of incident stroke: evidence from the PREVEND cohort

The Association Between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures Measured by Invasive Hemodynamic Monitoring

The Role of Comorbidities and Lifestyle Factors in Disease Progression of Phospholamban Cardiomyopathy

Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction

Age-related penetrance of phospholamban p.Arg14del cardiomyopathy

Pers/media

Hoe schadelijk zijn bier, wijn en sterke drank? Alcohol laat geen orgaan ongemoeid: dit gebeurt er in het lichaam als je alcohol drinkt

ESC-congres 2023 Gesprek van de dag | Hartfalen

FOCUS: praktische overwegingen bij starten van SGLT2-remmers bij hartfalen

De nieuwe ESC-hartfalenrichtlijn 2021 in het kort

Eerste kunsthart in Nederland geplaatst bij 54-jarige man

Dr Rudolf de Boer on SGLT2 Inhibitor Success Across Disease States

Nier- en HF-uitkomsten met SGLT2-remmer in het gehele EF spectrum in HF

Dr Rudolf de Boer Discusses Encouraging Trial Results on SGLT2 Use in HFpEF

Effecten van SGLT2-remmers in vogelvlucht

Sustainable Development Goals

SDG 2 – Geen hongerSDG 3 – Goede gezondheid en welzijnSDG 7 – Betaalbare en schone energieSDG 10 – Minder ongelijkheidSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.